Evidence map›Paper›PMID 41982593›Full record

ArticleCureus2026

Therapeutic Plasma Exchange for Severe Exogenous Thyrotoxicosis Following Massive Levothyroxine Ingestion: A Case Report.

Anas Kartoumah, Adam Abow Alkhier, Laith Kabbani, Noah Baranski, Muaz Mallah, Mohanad Horani, Mohamad Horani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anas KartoumahBiomedical Sciences, University of South Florida, Tampa, USA.
Adam Abow AlkhierBiomedical Engineering, Arizona State University, Phoenix, USA.
Laith KabbaniBiological Sciences, Arizona State University, Phoenix, USA.
Noah BaranskiBiological Sciences, Arizona State University, Phoenix, USA.
Muaz MallahBiological Sciences, Arizona State University, Phoenix, USA.
Mohanad HoraniCybersecurity, University of Advancing Technology, Tempe, USA.
Mohamad HoraniInternal Medicine, Chandler Regional Medical Center, Chandler, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Levothyroxine is among the most commonly prescribed medications worldwide and is generally safe at therapeutic doses; however, massive ingestion can result in severe exogenous thyrotoxicosis and delayed progression to thyroid storm. Management is challenging because clinical deterioration may occur days after ingestion due to the peripheral conversion of thyroxine (T4) to triiodothyronine (T3) and standard medical therapies do not directly remove circulating hormone. We report the case of a 70-year-old male patient with a massive levothyroxine overdose involving the ingestion of approximately 8,000 mcg, leading to worsening thyrotoxicosis with features concerning impending thyroid storm treated with beta-blockade, corticosteroids, and cholestyramine. Given the large intravascular burden of protein-bound T4 and clinical deterioration, therapeutic plasma exchange (TPE) was initiated. Serial TPE resulted in rapid biochemical improvement with marked reductions in free T4 levels and corresponding clinical stabilization. This case highlights the delayed and potentially misleading presentation of massive levothyroxine ingestion and demonstrates the effectiveness of TPE as a rescue therapy in severe exogenous thyrotoxicosis. Early recognition, prolonged monitoring, and consideration of TPE are essential when life-threatening symptoms emerge following massive levothyroxine overdose.

Indexed as

atrial fibrillationcholestyraminedexamethasoneexogenous thyrotoxicosislevothyroxine overdoseplasmapheresistachyarrhythmiatherapeutic plasma exchangethyroid stormtoxicology

Identifiers

PMID41982593
PMCPMC13075519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.